Search Results - "Kauvar, Lawrence"

Refine Results
  1. 1

    Human antibody repertoire frequently includes antibodies to a bacterial biofilm associated protein by Ryser, Stefan, Tenorio, Edgar, Estellés, Angeles, Kauvar, Lawrence M

    Published in PloS one (09-07-2019)
    “…We have previously described a native human monoclonal antibody, TRL1068, that disrupts bacterial biofilms by extracting from the biofilm matrix key…”
    Get full text
    Journal Article
  2. 2

    Advances in the Development of Therapeutics for Cytomegalovirus Infections by Acosta, Edward, Bowlin, Terry, Brooks, Jennifer, Chiang, Lillian, Hussein, Islam, Kimberlin, David, Kauvar, Lawrence M, Leavitt, Randi, Prichard, Mark, Whitley, Richard

    Published in The Journal of infectious diseases (05-03-2020)
    “…Abstract The development of therapeutics for cytomegalovirus (CMV) infections, while progressing, has not matched the pace of new treatments of human…”
    Get full text
    Journal Article
  3. 3

    A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I) by McVoy, Michael M, Tenorio, Edgar, Kauvar, Lawrence M

    “…Hyperimmune globulin (HIG) has shown efficacy against human cytomegalovirus (HCMV) for both transplant and congenital transmission indications. Replicating…”
    Get full text
    Journal Article
  4. 4

    Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity by Hijano, Diego R, Vu, Luan D, Kauvar, Lawrence M, Tripp, Ralph A, Polack, Fernando P, Cormier, Stephania A

    Published in Frontiers in immunology (26-03-2019)
    “…Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract disease in children <2 years of age. Increased morbidity and mortality…”
    Get full text
    Journal Article
  5. 5

    Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem by Tripp, Ralph A, Power, Ultan F, Openshaw, Peter J M, Kauvar, Lawrence M

    Published in Journal of virology (01-02-2018)
    “…Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection (LRTI) annually affecting >2 million children in the United States <5…”
    Get full text
    Journal Article
  6. 6

    Intrauterine Growth Restriction Caused by Underlying Congenital Cytomegalovirus Infection by Pereira, Lenore, Petitt, Matthew, Fong, Alex, Tsuge, Mitsuru, Tabata, Takako, Fang-Hoover, June, Maidji, Ekaterina, Zydek, Martin, Zhou, Yan, Inoue, Naoki, Loghavi, Sanam, Pepkowitz, Samuel, Kauvar, Lawrence M., Ogunyemi, Dotun

    Published in The Journal of infectious diseases (15-05-2014)
    “…Background. Human cytomegalovirus (HCMV) is the major viral etiology of congenital infection and birth defects. Fetal transmission is high (30%-40%) in primary…”
    Get full text
    Journal Article
  7. 7

    High affinity anti-TIM-3 and anti-KIR monoclonal antibodies cloned from healthy human individuals by Ryser, Stefan, Estellés, Angeles, Tenorio, Edgar, Kauvar, Lawrence M, Gishizky, Mikhail L

    Published in PloS one (19-07-2017)
    “…We report here the cloning of native high affinity anti-TIM-3 and anti-KIR IgG monoclonal antibodies (mAbs) from peripheral blood mononuclear cells (PBMC) of…”
    Get full text
    Journal Article
  8. 8

    Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes by Fedechkin, Stanislav O, George, Natasha L, Nuñez Castrejon, Ana M, Dillen, Joshua R, Kauvar, Lawrence M, DuBois, Rebecca M

    Published in Journal of virology (28-02-2020)
    “…Respiratory syncytial virus (RSV) is a top cause of severe lower respiratory tract disease and mortality in infants and the elderly. Currently, no vaccine or…”
    Get full text
    Journal Article
  9. 9

    Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells by Cui, Xiaohong, Freed, Daniel C, Wang, Dai, Qiu, Ping, Li, Fengsheng, Fu, Tong-Ming, Kauvar, Lawrence M, McVoy, Michael A

    Published in Journal of virology (01-07-2017)
    “…Cytomegalovirus (CMV) entry into fibroblasts differs from entry into epithelial cells. CMV also spreads cell to cell and can induce syncytia. To gain insights…”
    Get full text
    Journal Article
  10. 10

    Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta by Tabata, Takako, Petitt, Matthew, Zydek, Martin, Fang-Hoover, June, Larocque, Nicholas, Tsuge, Mitsuru, Gormley, Matthew, Kauvar, Lawrence M, Pereira, Lenore

    Published in Journal of virology (01-05-2015)
    “…Human cytomegalovirus (HCMV) is a major cause of birth defects that include severe neurological deficits, hearing and vision loss, and intrauterine growth…”
    Get full text
    Journal Article
  11. 11

    Inhibition of human cytomegalovirus entry into mucosal epithelial cells by He, Li, Hertel, Laura, James, Claire D., Morgan, Iain M., Klingelhutz, Aloysius J., Fu, Tong-Ming, Kauvar, Lawrence M., McVoy, Michael A.

    Published in Antiviral research (01-10-2024)
    “…Human cytomegalovirus (CMV) causes serious developmental disabilities in newborns infected in utero following oral acquisition by the mother. Thus,…”
    Get full text
    Journal Article
  12. 12

    Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens by Nuñez Castrejon, Ana M, O'Rourke, Sara M, Kauvar, Lawrence M, DuBois, Rebecca M

    Published in Journal of virology (13-04-2022)
    “…Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease of children, the elderly, and immunocompromised individuals…”
    Get full text
    Journal Article
  13. 13

    HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex by Zydek, Martin, Petitt, Matthew, Fang-Hoover, June, Adler, Barbara, Kauvar, Lawrence M, Pereira, Lenore, Tabata, Takako

    Published in Viruses (19-03-2014)
    “…Human cytomegalovirus (HCMV) is the major viral cause of congenital infection and birth defects. Primary maternal infection often results in virus…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response by Bergeron, Harrison C., Kauvar, Lawrence M., Tripp, Ralph A.

    Published in Therapeutic advances in infectious disease (01-01-2023)
    “…Background: Respiratory syncytial virus (RSV) is a poor inducer of antiviral interferon (IFN) responses which result in incomplete immunity and RSV disease…”
    Get full text
    Journal Article
  16. 16

    Native Human Antibody to Shr Promotes Mice Survival After Intraperitoneal Challenge With Invasive Group A Streptococcus by Chatterjee, Nilanjana, Huang, Ya-Shu, Lyles, Kristin V, Morgan, Julie E, Kauvar, Lawrence M, Greer, Susanna F, Eichenbaum, Zehava

    Published in The Journal of infectious diseases (23-04-2021)
    “…Abstract Background A vaccine against group A Streptococcus (GAS) has been actively pursued for decades. The surface receptor Shr is vital in GAS heme uptake…”
    Get full text
    Journal Article
  17. 17

    Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses by Vigil, Adam, Estélles, Angeles, Kauvar, Lawrence M, Johnson, Scott K, Tripp, Ralph A, Wittekind, Michael

    Published in Antimicrobial agents and chemotherapy (01-05-2018)
    “…Although antibodies that effectively neutralize a broad set of influenza viruses exist in the human antibody repertoire, they are rare. We used a single-cell…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein by Bergeron, Harrison C, Murray, Jackelyn, Arora, Aakash, Nuñez Castrejon, Ana M, DuBois, Rebecca M, Anderson, Larry J, Kauvar, Lawrence M, Tripp, Ralph A

    Published in Viruses (27-04-2023)
    “…The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants and the elderly. Immune prophylaxis in infants is currently…”
    Get full text
    Journal Article